Aclaris Therapeutics Ownership | Who Owns Aclaris Therapeutics?
Aclaris Therapeutics Ownership Summary
Aclaris Therapeutics is owned by 71.17% institutional investors, 2.24% insiders, and 26.59% retail investors. Bml capital management is the largest institutional shareholder, holding 11.62% of ACRS shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.04% of its assets in Aclaris Therapeutics shares.
ACRS Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Aclaris Therapeutics | 71.17% | 2.24% | 26.59% |
| Sector | Healthcare Stocks | 35.56% | 12.08% | 52.36% |
| Industry | Biotech Stocks | 35.43% | 12.01% | 52.56% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Bml capital management | 14.25M | 11.62% | $53.44M |
| Deep track capital, lp | 9.35M | 7.62% | $35.04M |
| Blackrock funding, inc. /de | 7.41M | 6.04% | $27.78M |
| Ra capital management | 6.80M | 5.55% | $25.52M |
| Vivo capital | 6.67M | 5.43% | $25.00M |
| Vanguard group | 6.50M | 5.30% | $19.57M |
| Frazier life sciences management | 4.93M | 4.02% | $18.47M |
| Rock springs capital management lp | 4.47M | 3.65% | $16.77M |
| Decheng capital | 4.04M | 3.29% | $15.16M |
| Adage capital partners gp | 3.87M | 3.16% | $14.52M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Bml capital management | 14.25M | 34.31% | $53.44M |
| Aldebaran capital | 947.16K | 2.72% | $3.55M |
| Decheng capital | 4.04M | 2.29% | $15.16M |
| Vivo capital | 6.67M | 2.09% | $25.00M |
| Monashee investment management | 500.00K | 1.02% | $1.88M |
| Rock springs capital management lp | 4.47M | 0.99% | $16.77M |
| Superstring capital management lp | 366.49K | 0.98% | $1.37M |
| Three bridge wealth advisors | 714.82K | 0.95% | $3.78M |
| Palo alto investors lp | 1.61M | 0.93% | $6.05M |
| Verdad advisers, lp | 197.04K | 0.83% | $738.91K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Deep track capital, lp | 9.35M | 0.57% | 9.35M |
| Ra capital management | 6.80M | 0.27% | 6.80M |
| Frazier life sciences management | 4.93M | 0.48% | 4.93M |
| Balyasny asset management | 3.36M | 0.02% | 3.36M |
| Braidwell lp | 1.70M | 0.21% | 1.70M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | 2.03M | 0.00% | -3.17M |
| Janus henderson group | - | - | -2.80M |
| Samsara biocapital | - | - | -2.39M |
| Vivo capital | 6.67M | 2.09% | -2.22M |
| Trium capital llp | - | - | -1.91M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Deep track capital, lp | 9.35M | 0.57% | 9.35M | $35.04M |
| Ra capital management | 6.80M | 0.27% | 6.80M | $25.52M |
| Frazier life sciences management | 4.93M | 0.48% | 4.93M | $18.47M |
| Balyasny asset management | 3.36M | 0.02% | 3.36M | $12.60M |
| Braidwell lp | 1.70M | 0.21% | 1.70M | $6.37M |
Sold Out
| Holder | Change |
|---|---|
| Clearstead advisors | -1.00 |
| Nelson, van denburg & campbell wealth management group | -14.00 |
| Srs capital advisors | -19.00 |
| Root financial partners | -27.00 |
| Innealta capital | -56.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 122 | -0.81% | 87,304,557 | 4.26% | 71 | 1.53% | 67 | 17.54% | 32 | -21.95% |
| Dec 31, 2025 | 24 | -76.70% | 24,077,074 | -71.90% | 19 | 0.40% | 12 | -72.09% | 5 | -87.18% |
| Sep 30, 2025 | 28 | -68.89% | 24,422,115 | -71.00% | 19 | 0.42% | 8 | -84.62% | 11 | -54.17% |
| Jun 30, 2025 | 95 | -12.04% | 91,849,906 | 7.52% | 74 | 1.54% | 56 | -9.68% | 25 | - |
| Mar 31, 2025 | 110 | 6.80% | 92,692,478 | 5.96% | 75 | 0.50% | 62 | 6.90% | 26 | 4.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 4.24M | 3.04% | 598.70K |
| Vanguard Morn Total Stk Mkt Idx Investor | 4.24M | 3.04% | 598.70K |
| iShares Russell 2000 ETF | 3.10M | 2.22% | 33.60K |
| Vanguard US Total Market Shares ETF | 2.12M | 1.96% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 1.45M | 1.04% | 343.70K |
| Xtrackers S&P 500 Swap ETF 1C | 916.55K | 0.76% | -6.76K |
| SQUAD Aguja Opportunities I | 500.00K | 0.70% | - |
| iShares Russell 2000 Growth ETF | 947.29K | 0.68% | - |
| Fidelity Small Cap Index | 911.89K | 0.65% | 3.91K |
| State Street® SPDR® S&P® PhrmctlsETF | 815.02K | 0.58% | 11.41K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Apr 23, 2026 | Leonard Braden Michael | - | Sell | $1.36M |
| Nov 19, 2024 | Mehra Anand | - | Buy | $1.50M |
| Aug 05, 2024 | Leonard Braden Michael | - | Buy | $256.36K |
| Aug 02, 2024 | Leonard Braden Michael | - | Buy | $216.40K |
| Jul 30, 2024 | Leonard Braden Michael | - | Buy | $226.37K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | - |
| 2025 Q4 | - | - |
| 2025 Q3 | - | - |
| 2025 Q2 | - | - |
| 2025 Q1 | - | - |
ACRS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools